RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/24299318http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24299318http://www.w3.org/2000/01/rdf-schema#comment"This article aimed to investigate the value of α-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma (HCC) and to evaluate the relationship between AFP and various clinical variables of HCC comprehensively. A retrospective study of postoperative patients diagnosed with liver neoplasm from two Chinese centers was enrolled in our study.A total of 3050 patients were included. The best cut-off point of AFP for the diagnosis of HCC was 20ng/ml with ideal sensitivity (69.74%), specificity (91.18%), LR (4.12) and YI (0.61). Non-HBV infection patients showed the highest specificity (94.44%) but lowest sensitivity (60.13%). In HBV infection. Patients, HBsAg, HBeAb, and HBcAb positive patients had the highest sensitivity (79.55%) and specificity (58.49%). AFP levels increased significantly in symptomatic patients (p=0.011). Those patients with tumor sizes ≥10cm had much higher serum AFP level compared with smaller tumors ones (p=0.014). AFP levels increased remarkably in patients with vascular invasion (p=0.015). Stepwise logistic regression showed tumor size (≥10cm) was an independent predictor of elevated AFP (OR=2.743, 95%CI: 1.167-6.447, P=0.021). The best discriminating AFP value for the diagnosis of HCC is 20ng/ml; HBsAg, HBeAb and HBcAb positive patients have the optimal sensitivity and specificity; tumor size ≥ 10cm is an independent predictor of elevated AFP."xsd:string
http://purl.uniprot.org/citations/24299318http://purl.org/dc/terms/identifier"doi:10.4149/neo_2014_028"xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/author"Xu G."xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/author"Zhang J.H."xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/author"Qin L.X."xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/author"Chen G.F."xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/author"Xu J.B."xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/author"Qi F.Z."xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/date"2014"xsd:gYear
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/name"Neoplasma"xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/pages"218-224"xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/title"Value of alpha-fetoprotein and clinical characteristics in patients with liver neoplasm."xsd:string
http://purl.uniprot.org/citations/24299318http://purl.uniprot.org/core/volume"61"xsd:string
http://purl.uniprot.org/citations/24299318http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24299318
http://purl.uniprot.org/citations/24299318http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/24299318
http://purl.uniprot.org/uniprot/#_B4DMW9-mappedCitation-24299318http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24299318
http://purl.uniprot.org/uniprot/#_B4DMX4-mappedCitation-24299318http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24299318
http://purl.uniprot.org/uniprot/#_P02771-mappedCitation-24299318http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24299318
http://purl.uniprot.org/uniprot/P02771http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24299318
http://purl.uniprot.org/uniprot/B4DMX4http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24299318
http://purl.uniprot.org/uniprot/B4DMW9http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24299318